Abu Dhabi Hospital Launches Early Alzheimer’s Detection Scan
Sheikh Shakhbout Medical City (SSMC) in Abu Dhabi has launched a cutting-edge brain imaging tool that detects Alzheimer’s disease well before symptoms appear. Using advanced PET scan technology, the tool identifies the early buildup of amyloid plaques, which are strongly linked to the development of Alzheimer’s. As a result, patients can benefit from earlier diagnoses, even when cognitive symptoms remain mild or unnoticed.
The new scan is especially useful for individuals with mild cognitive impairment or those with a family history of dementia. Moreover, it offers a more accurate assessment compared to conventional imaging methods. Because amyloid plaques often accumulate years before cognitive decline begins, early identification allows for timely intervention.
Improving Care Pathways and Patient Planning
While Alzheimer’s remains incurable, early detection plays a crucial role in managing the disease. With this tool, healthcare providers can begin treatment plans earlier, increasing the chances of slowing cognitive decline. Additionally, patients and their families gain more time to prepare emotionally, financially, and medically for future care needs.
The PET scan does more than confirm early Alzheimer’s. It also distinguishes the condition from other forms of dementia. Consequently, doctors can tailor treatment strategies based on the specific type of cognitive disorder, improving overall care outcomes.
A Step Forward for UAE Healthcare Innovation
The introduction of this technology highlights the UAE’s growing commitment to advanced healthcare solutions. Operated in collaboration with the Mayo Clinic, SSMC is one of the country’s leading hospitals driving innovation in medical diagnostics. This new brain imaging tool marks a significant step toward proactive neurological care, supporting national efforts to combat age-related diseases through early and precise intervention.
